Matraszek-Gawron Renata, Chwil Mirosława, Terlecki Karol, Skoczylas Michał Marian
Department of Botany and Plant Physiology, University of Life Sciences in Lublin, Akademicka 15 Street, 20-950 Lublin, Poland.
Department of Vascular Surgery and Angiology, Medical University of Lublin, Racławickie 1 Street, 20-059 Lublin, Poland.
Pharmaceuticals (Basel). 2022 Dec 30;16(1):58. doi: 10.3390/ph16010058.
Psychotropic effect of Crocus sativus L. (family Iridaceae) biologically active chemical compounds are quite well documented and they can therefore be used in addition to the conventional pharmacological treatment of depression. This systematic review on antidepressant compounds in saffron crocus and their mechanisms of action and side effects is based on publications released between 1995−2022 and data indexed in 15 databases under the following search terms: antidepressant effect, central nervous system, Crocus sativus, cognitive impairement, crocin, crocetin, depression, dopamine, dopaminergic and serotonergic systems, picrocrocin, phytotherapy, neurotransmitters, safranal, saffron, serotonin, and biologically active compounds. The comparative analysis of the publications was based on 414 original research papers. The investigated literature indicates the effectiveness and safety of aqueous and alcoholic extracts and biologically active chemical compounds (alkaloids, anthocyanins, carotenoids, flavonoid, phenolic, saponins, and terpenoids) isolated from various organs (corms, leaves, flower petal, and stigmas) in adjuvant treatment of depression and anxiety. Monoamine reuptake inhibition, N-methyl-d-aspartate (NMDA) receptor antagonism, and gamma-aminobutyric acid (GABA)-α agonism are the main proposed mechanism of the antidepressant action. The antidepressant and neuroprotective effect of extract components is associated with their anti-inflammatory and antioxidant activity. The mechanism of their action, interactions with conventional drugs and other herbal preparations and the safety of use are not fully understood; therefore, further detailed research in this field is necessary. The presented results regarding the application of C. sativus in phytotherapy are promising in terms of the use of herbal preparations to support the treatment of depression. This is particularly important given the steady increase in the incidence of this disease worldwide and social effects.
番红花(鸢尾科)生物活性化合物的精神药理作用已有充分记录,因此除了传统的抑郁症药物治疗外,它们也可被使用。这项关于藏红花中抗抑郁化合物及其作用机制和副作用的系统评价基于1995年至2022年间发布的出版物以及15个数据库中索引的数据,搜索词如下:抗抑郁作用、中枢神经系统、番红花、认知障碍、藏花素、藏红花酸、抑郁症、多巴胺、多巴胺能和血清素能系统、苦藏花素、植物疗法、神经递质、藏红花醛、藏红花、血清素和生物活性化合物。对这些出版物的比较分析基于414篇原创研究论文。所研究的文献表明,从不同器官(球茎、叶子、花瓣和柱头)中分离出的水提取物、醇提取物和生物活性化合物(生物碱、花青素、类胡萝卜素、黄酮类、酚类、皂苷和萜类)在辅助治疗抑郁症和焦虑症方面具有有效性和安全性。单胺再摄取抑制、N-甲基-D-天冬氨酸(NMDA)受体拮抗和γ-氨基丁酸(GABA)-α激动是主要提出的抗抑郁作用机制。提取物成分的抗抑郁和神经保护作用与其抗炎和抗氧化活性有关。它们的作用机制、与传统药物和其他草药制剂的相互作用以及使用安全性尚未完全了解;因此,有必要在该领域进行进一步的详细研究。就使用草药制剂辅助治疗抑郁症而言,所呈现的关于番红花在植物疗法中的应用结果很有前景。鉴于全球范围内这种疾病的发病率稳步上升及其社会影响,这一点尤为重要。